- Home
- NUKK vs BOLD Comparison
NUKK vs BOLD Comparison
Compare NUKK & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUKK
- BOLD
- Stock Information
- Founded
- NUKK 2013
- BOLD 2018
- Country
- NUKK United States
- BOLD United States
- Employees
- NUKK N/A
- BOLD N/A
- Industry
- NUKK Blank Checks
- BOLD
- Sector
- NUKK Finance
- BOLD
- Exchange
- NUKK Nasdaq
- BOLD Nasdaq
- Market Cap
- NUKK 25.4M
- BOLD 24.4M
- IPO Year
- NUKK N/A
- BOLD 2024
- Fundamental
- Price
- NUKK $4.78
- BOLD $1.15
- Analyst Decision
- NUKK
- BOLD Buy
- Analyst Count
- NUKK 0
- BOLD 4
- Target Price
- NUKK N/A
- BOLD $4.00
- AVG Volume (30 Days)
- NUKK 9.9M
- BOLD 73.8K
- Earning Date
- NUKK 11-14-2025
- BOLD 11-06-2025
- Dividend Yield
- NUKK N/A
- BOLD N/A
- EPS Growth
- NUKK N/A
- BOLD N/A
- EPS
- NUKK N/A
- BOLD N/A
- Revenue
- NUKK N/A
- BOLD N/A
- Revenue This Year
- NUKK N/A
- BOLD N/A
- Revenue Next Year
- NUKK N/A
- BOLD N/A
- P/E Ratio
- NUKK N/A
- BOLD N/A
- Revenue Growth
- NUKK N/A
- BOLD N/A
- 52 Week Low
- NUKK $1.30
- BOLD $1.00
- 52 Week High
- NUKK $78.32
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- NUKK 45.87
- BOLD 50.21
- Support Level
- NUKK $4.35
- BOLD $1.10
- Resistance Level
- NUKK $7.19
- BOLD $1.16
- Average True Range (ATR)
- NUKK 1.26
- BOLD 0.04
- MACD
- NUKK 0.26
- BOLD 0.00
- Stochastic Oscillator
- NUKK 18.75
- BOLD 60.00
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.